Long-term bivamelagon for hypothalamic obesity
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This long-term study tests a new drug, bivamelagon, for people with hypothalamic obesity. It's for those who already completed a similar study and tolerated the drug well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have finished an earlier study of this drug (LG-MCCL005) and tolerated it well.
- You need to use highly effective birth control during the study and for 3 months after your last dose.
- You must agree to avoid certain medications that could interfere with the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called mibavademab for people with severe obesity caused by changes in the leptin (LEP) gene. It aims to see if the drug can help with weight loss in children, teens, and adults who have this rare genetic condition.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This trial tests a new medicine called BGM0504 to help people with obesity lose weight. It may be an option if diet and exercise have not been enough and you qualify for a treatment study.
This trial tests an investigational drug called SGB-7342 to see if it helps with weight loss in people who are overweight or have obesity. It might be an option if you have a stable weight and haven't used certain weight-loss medications recently.
Hear when a new Hypothalamic Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.